MTAP immunohistochemistry is an accurate and reproducible surrogate for CDKN2A fluorescence in situ hybridization in diagnosis of malignant pleural mesothelioma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MTAP immunohistochemistry is an accurate and reproducible surrogate for CDKN2A fluorescence in situ hybridization in diagnosis of malignant pleural mesothelioma
Authors
Keywords
-
Journal
MODERN PATHOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-06-23
DOI
10.1038/s41379-019-0310-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Malignant mesothelioma in situ
- (2018) Andrew Churg et al. HISTOPATHOLOGY
- Utility of Methylthioadenosine Phosphorylase Compared With BAP1 Immunohistochemistry, and CDKN2A and NF2 Fluorescence In Situ Hybridization in Separating Reactive Mesothelial Proliferations From Epithelioid Malignant Mesotheliomas
- (2018) Kyra B. Berg et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Highlights of the 14th international mesothelioma interest group meeting: Pathologic separation of benign from malignant mesothelial proliferations and histologic/molecular analysis of malignant mesothelioma subtypes
- (2018) Andrew Churg et al. LUNG CANCER
- A combination of MTAP and BAP1 immunohistochemistry is effective for distinguishing sarcomatoid mesothelioma from fibrous pleuritic
- (2018) Yoshiaki Kinoshita et al. LUNG CANCER
- BAP1 Is Altered by Copy Number Loss, Mutation, and/or Loss of Protein Expression in More Than 70% of Malignant Peritoneal Mesotheliomas
- (2017) Noémie Leblay et al. Journal of Thoracic Oncology
- Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: Comparison with 9p21 FISH and BAP1 immunohistochemistry
- (2017) Tomoyuki Hida et al. LUNG CANCER
- What is your diagnosis? Bicavitary effusion in a horse
- (2017) Jill T. Schappa et al. VETERINARY CLINICAL PATHOLOGY
- Utility of BAP1 Immunohistochemistry and p16 (CDKN2A) FISH in the Diagnosis of Malignant Mesothelioma in Effusion Cytology Specimens
- (2016) Harry C. Hwang et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Loss of BAP1 expression is very rare in peritoneal and gynecologic serous adenocarcinomas and can be useful in the differential diagnosis with abdominal mesothelioma
- (2016) Juliana Andrici et al. HUMAN PATHOLOGY
- NCCN Guidelines Insights: Malignant Pleural Mesothelioma, Version 3.2016
- (2016) David S. Ettinger et al. Journal of the National Comprehensive Cancer Network
- Loss of expression of BAP1 is very rare in non-small cell lung carcinoma
- (2016) Juliana Andrici et al. PATHOLOGY
- Positive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesothelioma
- (2016) Michele Carbone et al. Oncotarget
- MTAP Deletions in Cancer Create Vulnerability to Targeting of the MAT2A/PRMT5/RIOK1 Axis
- (2016) Katya Marjon et al. Cell Reports
- Mesothelioma in the United States: a Surveillance, Epidemiology, and End Results (SEER)–Medicare investigation of treatment patterns and overall survival
- (2016) Jennifer Beebe-Dimmer et al. Clinical Epidemiology
- BAP1 Immunohistochemistry and p16 FISH to Separate Benign From Malignant Mesothelial Proliferations
- (2015) Brandon S. Sheffield et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- The evolving role of effusion cytology in the diagnosis of malignant mesothelioma
- (2015) A. Paintal CYTOPATHOLOGY
- BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma
- (2015) Stephanie M. McGregor et al. HUMAN PATHOLOGY
- BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations
- (2015) Marta Cigognetti et al. MODERN PATHOLOGY
- The diagnostic value of immunohistochemically detected methylthioadenosine phosphorylase deficiency in malignant pleural mesotheliomas
- (2012) Zarah Glad Zimling et al. HISTOPATHOLOGY
- CDKN2A and MTAP deletions in peritoneal mesotheliomas are correlated with loss of p16 protein expression and poor survival
- (2010) Alyssa M Krasinskas et al. MODERN PATHOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now